Adlai Nortye (ANL) Accumulated Expenses (2022 - 2025)

Adlai Nortye (ANL) reported Accumulated Expenses of $3.1 million for Q4 2025, up 2.64% year-over-year from $3.1 million in Q4 2024, and up 2.64% on a QoQ basis from $3.1 million in Q4 2024.

Adlai Nortye (ANL) has 4 years of Accumulated Expenses data on file, last reported at $3.1 million in Q4 2025.

  • Quarterly Accumulated Expenses rose 2.64% year-over-year to $3.1 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $3.1 million (up 2.64% YoY) and the FY2025 annual result came in at $3.1 million, up 2.64% from the prior year.
  • Accumulated Expenses climbed to $3.1 million in Q4 2025 per ANL's latest filing, from $3.1 million in the prior quarter.
  • Across five years, Accumulated Expenses topped out at $3.8 million in Q4 2023 and bottomed at $3.1 million in Q4 2024.
  • The 4-year median for Accumulated Expenses is $3.4 million (2022), against an average of $3.4 million.
  • The widest annual swing landed in 2023, when Accumulated Expenses gained 5.3%; it then slipped 19.69% in 2024.
  • Tracing ANL's Accumulated Expenses over 4 years: stood at $3.6 million in 2022, then advanced by 5.3% to $3.8 million in 2023, then dropped by 19.69% to $3.1 million in 2024, then advanced by 2.64% to $3.1 million in 2025.
  • Per Business Quant, the three latest ANL Accumulated Expenses figures stand at $3.1 million (Q4 2025), $3.1 million (Q4 2024), and $3.8 million (Q4 2023).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 1,638,563.89 Bn 1,638,563.89 Bn -
2 Alterity Therapeutics 767,934.24 Bn 767,934.20 Bn -
3 Legend Biotech 2,937.00 Bn 2,936.10 Bn 242.10 Mn
4 Nanobiotix 2,282.79 Bn 2,282.72 Bn -
5 Akari Therapeutics 2,169.69 Bn 2,169.69 Bn -
6 Vertex Pharmaceuticals 110.41 Bn 103.16 Bn 2.59 Bn
7 Regeneron Pharmaceuticals 66.44 Bn 57.69 Bn 3.31 Bn
8 Evaxion A 65.44 Bn 65.42 Bn -
9 Alnylam Pharmaceuticals 39.53 Bn 36.52 Bn 959.66 Mn
10 Adlai Nortye 23,840.00 -8.03 Mn -

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 3.14 Mn
Dec 31, 2024 3.06 Mn
Dec 31, 2023 3.81 Mn
Dec 31, 2022 3.62 Mn